1. Home
  2. NKTR vs BLDE Comparison

NKTR vs BLDE Comparison

Compare NKTR & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NKTR
  • BLDE
  • Stock Information
  • Founded
  • NKTR 1990
  • BLDE 2014
  • Country
  • NKTR United States
  • BLDE United States
  • Employees
  • NKTR N/A
  • BLDE N/A
  • Industry
  • NKTR Biotechnology: Pharmaceutical Preparations
  • BLDE Aerospace
  • Sector
  • NKTR Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • NKTR Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • NKTR 238.7M
  • BLDE 276.7M
  • IPO Year
  • NKTR 1994
  • BLDE N/A
  • Fundamental
  • Price
  • NKTR $1.28
  • BLDE $3.48
  • Analyst Decision
  • NKTR Buy
  • BLDE
  • Analyst Count
  • NKTR 4
  • BLDE 0
  • Target Price
  • NKTR $2.50
  • BLDE N/A
  • AVG Volume (30 Days)
  • NKTR 1.1M
  • BLDE 513.9K
  • Earning Date
  • NKTR 11-05-2024
  • BLDE 11-06-2024
  • Dividend Yield
  • NKTR N/A
  • BLDE N/A
  • EPS Growth
  • NKTR N/A
  • BLDE N/A
  • EPS
  • NKTR N/A
  • BLDE N/A
  • Revenue
  • NKTR $93,157,000.00
  • BLDE $238,379,000.00
  • Revenue This Year
  • NKTR N/A
  • BLDE $12.14
  • Revenue Next Year
  • NKTR N/A
  • BLDE $11.35
  • P/E Ratio
  • NKTR N/A
  • BLDE N/A
  • Revenue Growth
  • NKTR 6.17
  • BLDE 25.39
  • 52 Week Low
  • NKTR $0.41
  • BLDE $2.06
  • 52 Week High
  • NKTR $1.93
  • BLDE $4.25
  • Technical
  • Relative Strength Index (RSI)
  • NKTR 52.48
  • BLDE 60.43
  • Support Level
  • NKTR $1.24
  • BLDE $3.37
  • Resistance Level
  • NKTR $1.39
  • BLDE $3.58
  • Average True Range (ATR)
  • NKTR 0.09
  • BLDE 0.14
  • MACD
  • NKTR 0.01
  • BLDE 0.03
  • Stochastic Oscillator
  • NKTR 61.29
  • BLDE 84.81

About NKTR Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: